Related Experiment Video
Updated: Apr 4, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Interaction between HCMV infection and PAX9 gene polymorphisms in low birth weight infants
Ning Cheng1, Dennis Wang2,3, Zhihui Zhou1
1a Center for Reproductive Health and Birth Defects, College of Basic Medicine, Lanzhou University , Lanzhou , Gansu , PR China .
Insights
Human cytomegalovirus (HCMV) infection significantly increases the risk of low birth weight (LBW) in infants. Certain PAX9 gene variations may further elevate this risk in HCMV-infected newborns.
Area of Science:
- Medical Genetics
- Infectious Diseases
- Neonatology
Background:
- Human cytomegalovirus (HCMV) is a common congenital infection.
- Low birth weight (LBW) is a significant global health concern.
- The role of specific gene polymorphisms in HCMV-related LBW is not fully understood.
Purpose of the Study:
- To investigate the association between HCMV infection and PAX9 gene polymorphisms in infants with LBW.
- To determine if PAX9 gene variations modify the risk of LBW in HCMV-infected infants.
Main Methods:
- Nested-PCR was used to detect HCMV infection in infants.
- Restriction fragment length polymorphism PCR (RFLP-PCR) identified PAX9 gene polymorphisms (rs2073244 and rs4904210).
- Statistical analyses, including χ(2) tests and logistic regressions, compared LBW rates between HCMV-positive and negative groups, and assessed gene-environment interactions.
Main Results:
- HCMV infection was significantly associated with LBW (OR = 5.519, p < 0.05).
- Specific PAX9 genotypes (AG/GG at rs2073244, CC at rs4904210) showed interaction coefficients suggesting they may enhance the LBW risk in HCMV-infected infants.
- These findings indicate a potential interplay between HCMV and PAX9 in the etiology of LBW.
Conclusions:
- Congenital HCMV infection is a confirmed cause of LBW.
- Certain PAX9 polymorphisms can increase the susceptibility to LBW in infants with HCMV infection.
- This research provides a basis for further molecular epidemiological and biochemical studies on HCMV, PAX9, and LBW.
Objective:
To investigate the interaction between human cytomegalovirus infection and PAX9 gene polymorphisms in low birth weight (LBW) infants.
Methods:
Nested-PCR was used to detect human cytomegalovirus (HCMV) infection and restriction fragment length polymorphism PCR (RFLP-PCR) was then used to detect polymorphisms at rs2073244 and rs4904210 on the PAX9 gene in 65 HCMV-positive infant cases and 65 HCMV-negative infant controls. Cases and controls were compared for differences in the rates of LBW using the χ(2) test. Genetic and environmental interactions were assessed by comparing rates of LBW between the cases and controls in stratified analyses and logistic regressions.
Results:
The study confirmed that HCMV infection is significantly associated with LBW (OR = 5.519, χ(2) = 20.924, p < 0.05) and suggested that some PAX9 polymorphisms may promote the induction of LBW by HCMV infection. The AG and GG genotypes at rs2073244 and the CC genotype at rs4904210, with interaction coefficients greater than unity suggest that they may strengthen the association between HCMV infection and LBW.
Conclusions:
Congenital HCMV infection can cause LBW and some PAX9 polymorphisms can increase the risk of LBW in HCMV-infected infants. The results may provide new clues into the relationship among HCMV infection, PAX9 polymorphisms and LBW as well as a foundation for additional molecular epidemiological and biochemical research in the future.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Single Nucleotide Polymorphisms-SNPs
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

